Jim Cramer on Dendreon
by Jon C. Ogg
24/7 Wall ST.
Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon (DNDN-NASDAQ). What he said was that he thinks it can still go up and that it will probably still go higher.
He was very explicit though about the risks after such a huge week last week and even this week that it is very speculative and very risky. He noted how CNBC’s Mike Huckman called it right about the risk-reward being so huge with upside.
DNDN closed up almost 3% at $15.08 on over 13 million shares, and it ticked up a bit less than 1% to $15.19 after he cautiously was positive on it.
Source: 247WallSt.com
RELATED READING:
- Right on, Dendreon!
- Will Dendreon’s Cancer Vaccine Win Final FDA Approval?
- Dendreon: Massive Pre-Market Action
_____________________
Comments
Leave a Reply
You must be logged in to post a comment.